No abstract available
MeSH terms
-
Anticoagulants / adverse effects
-
Anticoagulants / therapeutic use
-
Atrial Fibrillation* / complications
-
Atrial Fibrillation* / drug therapy
-
Dabigatran / adverse effects
-
Fibrinolytic Agents* / adverse effects
-
Fibrinolytic Agents* / therapeutic use
-
Hemorrhage / chemically induced
-
Humans
-
Ischemia / chemically induced
-
Pyrazoles / adverse effects
-
Pyrazoles / therapeutic use
-
Pyridones / adverse effects
-
Pyridones / therapeutic use
-
Rivaroxaban* / adverse effects
-
Rivaroxaban* / therapeutic use
-
Stroke / etiology
-
Stroke / prevention & control
Substances
-
Anticoagulants
-
Fibrinolytic Agents
-
Pyrazoles
-
Pyridones
-
apixaban
-
Rivaroxaban
-
Dabigatran